SCHEMBL296230

SCHEMBL296230

COc1ccccc1-n1c(=O)[nH]c2c(C(N)=O)nc(-c3cccc(O)c3F)nc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.72
ALDH1A1 P00352 4/20 0.72
HSD17B10 Q99714 6/20 0.67
HPGD P15428 5/20 0.67
USP2 O75604 4/20 0.67
TSHR P16473 4/20 0.67
NPSR1 Q6W5P4 4/20 0.67
GAA P10253 3/20 0.67
BRCA1 P38398 2/20 0.67
MAPK1 P28482 2/20 0.67
GLA P06280 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
MAPT P10636 2/20 0.60
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
RXFP1 Q9HBX9 2/20 0.58
LMNA P02545 3/20 0.57
ALPL P05186 1/20 0.55
ALPI P09923 1/20 0.55
ALPG P10696 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL297577 0.89 KDM4E (0.69) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL27796460 0.85 KDM4E (0.70) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL300827 0.85 KDM4E (0.73) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL301309 0.83 KDM4E (0.68) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL296211 0.83 KDM4E (0.71) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL292729 0.82 KDM4E (0.67) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL291560 0.82 KDM4E (0.81) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL300846 0.82 KDM4E (0.69) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL19207479 0.82 KDM4E (0.74) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL300886 0.82 KDM4E (0.66) KDM4EALDH1A1HSD17B10HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-B1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARM LLC (US) 2012-03-14 EP claimed
CN-110721186-A Treatment of prostate cancer with TOR kinase inhibitors 西格诺药品有限公司 2020-01-24 CN disclosed
CN-107157990-B Treatment of cancer with TOR kinase inhibitors 西格诺药品有限公司 2020-01-07 CN disclosed
CN-102821767-A IDENTIFICATION OF LKB1 MUTATION AS A PREDICTIVE BIOMARKER FOR SENSITIVITY TO TOR KINASE INHIBITORS SIGNAL PHARM LLC 2012-12-12 CN disclosed